Warning labels on Mounjaro, Ozempic, and a whole host of other similar type 2 diabetes drugs list gastrointestinal problems, such as the following, as potential side effects associated with them: Abdominal discomfort or pain Nausea Bloating Vomiting Constipation Discolored stools Indigestion Diarrhea However, in entering Ozempic, Mounjaro, and other similar medications into the FDA Adverse Events Reporting System (FAERS) Public Dashboard, thousands of reports of much more serious adverse side effects, including the following, come up: Pancreatitis Gallbladder issues Kidney failure Thyroid tumors Cancer Gastroparesis Gastroparesis, also known as stomach paralysis, is what has led to many patients filing lawsuits against the drugs manufacturers most recently
Compounded oral tirzepitide is made in response to FDA-recognized shortages of the commercially available drug
This is the second group of warning letters sent since a September crackdown on misleading direct-to-consumer pharmaceutical advertisements was launched following US President Donald Trumps order for tighter oversight of how companies promote prescription drugs
Patients on this medication experience weight loss, but it is not approved for managing obesity
Even small amounts of protein throughout the day are better than skipping meals entirely
Breast Cancer EHR Cohort Study Design In the present study, researchers investigated the associations between GLP-1RA use and all-cause mortality and RFS in patients with BC
&srotate=0)
